Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.

Gilead Sciences (NASDAQ: GILD)

GILD 71.69
0.31 (0.4%)

Open: 71.48 High: 72.11 Low: 71.30

TR N

External Links

52WL $56.56

The 52 Week Low is $56.56 set on Wed, Dec 30, 2020. The current price, $71.69, is 27% above the 52 Week Low.

52WH $73.09

The 52 Week High is $73.09 set on Tue, Aug 17, 2021.

ATH $122.40

The All-Time High is $122.40 set on Tue, Jun 23, 2015. The current price, $71.69, is 41% below the All Time High.

52 Week Range

$56.56
$73.09
Dec 30, 2020
Aug 17, 2021

GILD Earnings


Q1 Earnings for Jan, Feb & Mar

Thu, Apr 29, 2021

Since Q1 Earnings Report

GILD 11.3%


Q2 Earnings for Apr, May & Jun

Thu, Jul 29, 2021

Since Q2 Earnings Report

GILD 2.3%

GILD Profile

Gilead Sciences trades on the NASDAQ. GILD's market cap is 89.5 Billion.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Website

Related Channels

YouTube Symbol Surfing

Watch these videos to learn how Symbol Surfing can increase your trading and investing knowledge and results.